21 May 2013
Keywords: oral, pmpa, enters, phase, ii, gilead, sciences
Article | 10 September 1998
Gilead Sciences has started enrollment in its Phase II study of anoral prodrug of PMPA for the treatment of HIV. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 1998
9 September 1998
© 2013 thepharmaletter.com